Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement

Trial Profile

Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Dec 2017

At a glance

  • Drugs Denosumab (Primary)
  • Indications Male osteoporosis; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 01 Jun 2017 Planned End Date changed from 1 May 2017 to 1 Feb 2018.
    • 01 Jun 2017 Planned primary completion date changed from 1 May 2017 to 1 Feb 2018.
    • 04 Feb 2016 Planned End Date changed from 1 Oct 2017 to 1 May 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top